Safety of tocilizumab in patients with rheumatoid arthritis: Pooled analysis of five phase 3 clinical trials

被引：0
|
作者：
Smolen, Josef S. [1 ]
Beaulieu, Andre D. [2 ]
Dikranian, Ara [3 ]
Fenton, Ira [4 ]
Fisheleva, Elena
Alecock, Emma
Emery, Paul [5 ]
机构：
[1] Med Univ, Vienna, Austria
[2] Ctr Rhumatol, St Louis, PQ, Canada
[3] Arthrit Med Clin, San Diego, CA USA
[4] Deerbrook Med Associates, Vernon Hills, IL USA
[5] St James Univ, Leeds, W Yorkshire, England
来源：
ARTHRITIS AND RHEUMATISM | 2008年 / 58卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S784 / S784
页数：1
相关论文
共 50 条
  • [1] Hepatic Aminotransferases and Bilirubin Levels During Tocilizumab Treatment of Patients with Rheumatoid Arthritis: Pooled Analysis of Five Phase 3 Clinical Trials
    Bykerk, Vivian P.
    Kremer, Joel M.
    Keystone, Edward C.
    [J]. JOURNAL OF RHEUMATOLOGY, 2009, 36 (11) : 2591 - 2591
  • [2] Hepatic aminotransferases and bilirubin levels during tocilizumab treatment of patients with rheumatoid arthritis: Pooled analysis of five phase 3 clinical trials
    Kremer, Joel M.
    Joh, Ani K.
    Malamet, Raymond
    Keystone, Ed C.
    [J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S783 - S783
  • [3] Lipid and inflammatory biomarker profiles in patients receiving tocilizumab for rheumatoid arthritis: Analysis of five phase 3 clinical trials
    Genovese, Mark C.
    Smolen, Josef S.
    Emery, Paul
    Jones, Graeme
    Lee, Janet S.
    Alecock, Emma
    Kremer, Joel M.
    [J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S531 - S532
  • [4] Effect of tocilizumab on neutrophils in adult patients with rheumatoid arthritis: pooled analysis of data from phase 3 and 4 clinical trials
    Moots, Robert J.
    Sebba, Anthony
    Rigby, William
    Ostor, Andrew
    Porter-Brown, Benjamin
    Donaldson, Francis
    Dimonaco, Sophie
    Rubbert-Roth, Andrea
    van Vollenhoven, Ronald
    Genovese, Mark C.
    [J]. RHEUMATOLOGY, 2017, 56 (04) : 541 - 549
  • [5] Low immunogenic potential of tocilizumab in patients with rheumatoid arthritis: Analysis of four phase 3 clinical trials
    Ramos-Remus, Cesar
    Genovese, Mark C.
    Harre, Robert A.
    Woodworth, Thasia
    Alecock, Emma
    [J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S534 - S534
  • [6] LONG-TERM SAFETY OF TOCILIZUMAB IN RHEUMATOID ARTHRITIS CLINICAL TRIALS
    Taylor, A.
    Nash, P.
    Hall, S.
    Jones, G.
    Youssef, P.
    Porter-Brown, B.
    Thompson, L.
    Genovese, M.
    [J]. INTERNAL MEDICINE JOURNAL, 2012, 42 : 14 - 14
  • [7] LONG-TERM SAFETY OF TOCILIZUMAB IN RHEUMATOID ARTHRITIS CLINICAL TRIALS
    Genovese, Mark C.
    Sebba, Anthony
    Rubbert-Roth, Andrea
    Scali, Juan
    Zilberstein, Moshe
    Thompson, Liz
    Van Vollenhoven, Ronald
    [J]. RHEUMATOLOGY, 2012, 51 : 75 - 76
  • [8] Clinical safety of tocilizumab in rheumatoid arthritis
    Bannwarth, Bernard
    Richez, Christophe
    [J]. EXPERT OPINION ON DRUG SAFETY, 2011, 10 (01) : 123 - 131
  • [9] EFFECTS OF SMOKING ON BARICITINIB EFFICACY IN PATIENTS WITH RHEUMATOID ARTHRITIS: POOLED ANALYSIS FROM TWO PHASE 3 CLINICAL TRIALS
    Curtis, J.
    Emery, P.
    Burmester, G.
    Arora, V.
    Alam, J.
    Muram, D.
    Klareskog, L.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 244 - 244
  • [10] Concomitant use of statins in tocilizumab-treated patients with rheumatoid arthritis with elevated low density lipoprotein cholesterol: Analysis of five phase 3 clinical trials
    Genovese, Mark C.
    Smolen, Josef S.
    Emery, Paul
    Jones, Graeme
    Lee, Janet S.
    Alecock, Emma
    Kremer, Joel M.
    [J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S785 - S786
12345